Intuitive Surgical, Inc. $ISRG Shares Sold by Foundations Investment Advisors LLC

Foundations Investment Advisors LLC lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 93.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,715 shares of the medical equipment provider’s stock after selling 37,895 shares during the period. Foundations Investment Advisors LLC’s holdings in Intuitive Surgical were worth $1,214,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the business. Strategic Advisors LLC raised its holdings in shares of Intuitive Surgical by 63.3% in the third quarter. Strategic Advisors LLC now owns 10,397 shares of the medical equipment provider’s stock valued at $4,650,000 after buying an additional 4,031 shares during the last quarter. AE Wealth Management LLC raised its stake in Intuitive Surgical by 18.9% during the 3rd quarter. AE Wealth Management LLC now owns 11,556 shares of the medical equipment provider’s stock valued at $5,168,000 after acquiring an additional 1,836 shares during the last quarter. LRI Investments LLC lifted its position in Intuitive Surgical by 24.0% during the 3rd quarter. LRI Investments LLC now owns 1,997 shares of the medical equipment provider’s stock worth $893,000 after acquiring an additional 387 shares during the period. Birchbrook Inc. grew its stake in shares of Intuitive Surgical by 5.1% in the 3rd quarter. Birchbrook Inc. now owns 1,533 shares of the medical equipment provider’s stock valued at $686,000 after purchasing an additional 74 shares during the last quarter. Finally, Activest Wealth Management grew its stake in shares of Intuitive Surgical by 21.7% in the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock valued at $50,000 after purchasing an additional 20 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: TD Cowen upgraded ISRG and said the company’s long‑run growth is likely underestimated, supporting a higher multi‑year earnings outlook and raising optimism among growth investors. Intuitive Surgical Inc.’s (ISRG) long-run growth underestimated, says TD Cowen
• Positive Sentiment: Q4/earnings-call takeaways: analysts pressed management on growth drivers and margin outlook, but the quarter showed solid revenue and EPS beats that underpin the company’s recurring parts & services revenue model. That confirms continued demand for da Vinci systems and supports forward estimates. 5 Revealing Analyst Questions From Intuitive Surgical’s Q4 Earnings Call
• Positive Sentiment: Regulatory/product progress: coverage of cardiac clearance work and the rollout of the da Vinci 5 platform suggests new procedure types and market expansion that could lift system sales and higher‑margin consumables over time. Intuitive Surgical’s Cardiac Clearance Tests Valuation As da Vinci 5 Expands
• Positive Sentiment: Analyst/bull commentary: sector bulls and outlets (e.g., Zacks) remain positive on the da Vinci franchise and recurring revenue stream, reinforcing investor conviction on long‑term durability. Bull of the Day: Intuitive Surgical (ISRG)
• Neutral Sentiment: Valuation debate persists: retail analyst pieces note 2025 results were strong but warn the stock’s premium valuation is the main risk — strong fundamentals vs. expensive multiples keeps investor views mixed. Should You Buy Shares of Intuitive Surgical In February?
• Negative Sentiment: Insider selling: EVP Myriam Curet sold small blocks of ISRG shares in recent transactions (e.g., 126 shares at ~$520). The amounts are modest but such filings can create short‑term selling pressure or signal personal diversification. Intuitive Surgical (NASDAQ:ISRG) EVP Myriam Curet Sells 126 Shares

Analysts Set New Price Targets

ISRG has been the subject of several recent research reports. Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. Citigroup restated a “neutral” rating and set a $590.00 price objective (down previously from $635.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Daiwa Capital Markets boosted their price target on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Leerink Partners increased their price target on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Finally, Evercore ISI lowered their price objective on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a report on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $620.41.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $504.22 on Friday. The firm has a market capitalization of $180.75 billion, a price-to-earnings ratio of 63.91, a price-to-earnings-growth ratio of 3.92 and a beta of 1.67. The business’s 50 day simple moving average is $558.64 and its 200-day simple moving average is $511.63. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s revenue was up 18.8% on a year-over-year basis. During the same period in the previous year, the firm posted $2.21 earnings per share. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, VP Fredrik Widman sold 2,067 shares of the business’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $550.00, for a total value of $1,136,850.00. Following the sale, the vice president directly owned 473 shares in the company, valued at $260,150. The trade was a 81.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Henry L. Charlton sold 13,731 shares of the stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the sale, the executive vice president directly owned 3,056 shares in the company, valued at approximately $1,772,480. The trade was a 81.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 75,683 shares of company stock worth $42,066,425. Insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.